Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
472 Leser
Artikel bewerten:
(2)

Neutra Corp: Neutra Poised for Greater Growth as Another Successful Year Comes to a Close

KATY, TX / ACCESSWIRE / December 18, 2020 / Neutra Corporation (OTC PINK:NTRR) has enjoyed a year of important milestones and achievements that have set up the company for a strong 2021. These accomplishments are even more impressive considering the world saw the onset of a global pandemic in March that continues to this day.

Among the biggest highlights for 2020 include:

  • a fresh influx of funding
  • the retiring of convertible debt
  • the granting of hemp processing and handling from the state of Texas
  • the opening of manufacturing facilities in the Greater Houston area
  • the rollout of several new zero-THC products, including Broad-Spectrum CBD Products
  • expansion into equipment rental and consulting
  • and finally, the hiring of a national sales team

"It's obviously been a year of great challenges because of COVID, but thanks to careful planning and a lot of hard work, Neutra is wrapping up its most successful year to date," said CEO Sydney Jim. "I'm proud to inform our valued shareholders that we've met our goals for the year and we're aiming much higher for 2021. We're in a great position to accomplish even greater things in the coming 12 months in no small part due to our past success."

One of the items that will help Neutra get off to a good start next is a new pain cream to be produced by its VIVIS subsidiary. This pain cream will deliver superior relief for users through a broad spectrum CBD dosage of 1000 mg. The market potential for this pain cream is vast as more than 116 million Americans suffer from chronic pain issues.

To learn more about these and other VIVIS hemp-based CBD products, visit the company's website at http://viviscbd.com.

About Neutra Corp.

Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at http://www.NeutraInc.com.

NOTICE REGARDING FORWARD LOOKING STATEMENT

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.

Neutra Contact:

Sydney Jim
888-433-4033
info@neutrainc.com

SOURCE: Neutra Corp



View source version on accesswire.com:
https://www.accesswire.com/621525/Neutra-Poised-for-Greater-Growth-as-Another-Successful-Year-Comes-to-a-Close

© 2020 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.